Is low-risk MDS really low risk? (with Prof Uwe Platzbecker)
Failed to add items
Add to Cart failed.
Add to Wish List failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
Is low-risk MDS really low risk? (with Prof Uwe Platzbecker)
-
Narrated by:
-
By:
About this listen
Join Professor Kirsten Gronbaek and Professor Uwe Platzbecker as they discuss the complexities behind the classification and prognostication of low-risk myelodysplastic syndromes (MDS). They dive into the historical context of MDS classification, the evolution of prognostic indexes such as IPSS and IPSSM, and the implications of recent molecular findings.
This conversation highlights the challenges in defining "low-risk" MDS, the role of genetic mutations in prognosis, and the considerations for treatment strategies, including the potential for stem cell transplantation.
Host: Professor Kirsten Gronbaek, University of Copenhagen, Denmark
Guest: Professor Uwe Platzbecker, University Clinic of Leipzig
Learn More
What did you think of this podcast? Share your opinions with us in this short feedback survey.
https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1
Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.
https://ehaedu.org/Campus
Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.
Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/
Facebook: https://e-h-a.link/facebook
LinkedIn: https://www.linkedin.com/company/eha/
Email us: education@ehaweb.org
Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe